Peter Eichhorn
Overview
Explore the profile of Peter Eichhorn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Konen F, Wurster U, Schwenkenbecher P, Gerritzen A, Gross C, Eichhorn P, et al.
Autoimmun Rev
. 2025 Feb;
24(5):103765.
PMID: 39947571
Background: The 2024-revised McDonald criteria for multiple sclerosis (MS) proposed to incorporate cerebrospinal fluid (CSF)-specific oligoclonal bands and kappa free light chains (KFLC) as diagnostic biomarkers. While the 2017-revised criteria...
2.
Winklmeier S, Rubsamen H, Ozdemir C, Wratil P, Lupoli G, Stern M, et al.
Front Immunol
. 2024 Feb;
15:1330864.
PMID: 38375482
The mucosal immunity is crucial for restricting SARS-CoV-2 at its entry site. Intramuscularly applied vaccines against SARS-CoV-2 stimulate high levels of neutralizing Abs in serum, but the impact of these...
3.
Maurus I, Wagner S, Campana M, Roell L, Strauss J, Fernando P, et al.
BJPsych Open
. 2023 Apr;
9(3):e60.
PMID: 37038760
Background: Even before the onset of psychotic symptoms, individuals with schizophrenia display cognitive impairments. Simultaneously, increasing amounts of individuals exhibit dysfunction of the blood-brain barrier (BBB). However, the impact of...
4.
Campana M, Lohrs L, Strauss J, Munz S, Oviedo-Salcedo T, Fernando P, et al.
Eur Arch Psychiatry Clin Neurosci
. 2023 Mar;
273(8):1693-1701.
PMID: 36869234
Vitamin deficiency syndromes and blood-brain barrier (BBB) dysfunction are frequent phenomena in psychiatric conditions. We analysed the largest available first-episode schizophrenia-spectrum psychosis (FEP) cohort to date regarding routine cerebrospinal fluid...
5.
Biljecki M, Eisenhut K, Beltran E, Winklmeier S, Mader S, Thaller A, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Feb;
10(3).
PMID: 36823135
Background And Objectives: Antibodies (Abs) against the cytoplasmic protein glutamic acid decarboxylase 65 (GAD65) are detected in patients with neurologic syndromes together referred to as GAD65-Ab spectrum disorders. The response...
6.
Winklmeier S, Eisenhut K, Taskin D, Rubsamen H, Gerhards R, Schneider C, et al.
iScience
. 2021 Dec;
25(1):103659.
PMID: 34957380
Although some COVID-19 patients maintain SARS-CoV-2-specific serum immunoglobulin G (IgG) for more than 6 months postinfection, others eventually lose IgG levels. We assessed the persistence of SARS-CoV-2-specific B cells in...
7.
Oviedo-Salcedo T, Wagner E, Campana M, Gagsteiger A, Strube W, Eichhorn P, et al.
Transl Psychiatry
. 2021 Dec;
11(1):621.
PMID: 34880213
Multiple lines of evidence indicate that immunological and inflammatory alterations contribute at least in a subgroup to the pathophysiology of schizophrenia. In this retrospective chart review, we investigated whether clinical...
8.
Eisenhut K, Buchka S, Eichhorn P, Meier H, Albashiti F, Mansmann U, et al.
J Neurol
. 2021 Oct;
269(3):1133-1137.
PMID: 34609601
No abstract available.
9.
Campana M, Strauss J, Munz S, Oviedo-Salcedo T, Fernando P, Eichhorn P, et al.
Schizophr Bull
. 2021 Sep;
48(1):47-55.
PMID: 34480476
Background: The role of inflammatory processes in the etiology of schizophrenia is increasingly being investigated. A link between psychosis and inflammation measured with different biomarkers has been reported in the...
10.
Geyer P, Arend F, Doll S, Louiset M, Virreira Winter S, Muller-Reif J, et al.
EMBO Mol Med
. 2021 Jul;
13(8):e14167.
PMID: 34232570
A deeper understanding of COVID-19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)-based...